Inflammatory Bowel Disease Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Afib Ablation and Mental Health, Sedentary Behavior and Dementia, Ulcerative Colitis Review, and more
Editor’s Summary by Christopher W. Seymour, MD, MSc, Associate Editor of JAMA, the Journal of the American Medical Association, for the September 12, 2023, issue. Related Content: Audio Highlights (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - September 12, 2023 Category: General Medicine Authors: JAMA Network Source Type: podcasts

Intrapartum Azithromycin and Neonatal and Maternal Outcomes, Olamkicept for Ulcerative Colitis, FDA Mandate Limiting Acetaminophen in Combination Opioid Products and Liver Failure, and more
Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, The Journal of the American Medical Association, for the March 7, 2023, issue. (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - March 7, 2023 Category: General Medicine Authors: JAMA Network Source Type: podcasts

Initial safety trial results find increased risk of serious heart-related problems and cancer with arthritis and ulcerative colitis medicine Xeljanz, Xeljanz XR (tofacitinib)
Listen to FDA Drug Safety Podcast on Drug Safety Communication titled "Initial safety trial results find increased risk of serious heart-related problems and cancer with tofacitinib (Xeljanz, Xeljanz XR) (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - February 8, 2021 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts

Effect of Tri- vs Quadrivalent Flu Vaccination on Mortality, COPD Exacerbation and VTE, Review of Crohn Disease, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 5, 2021 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - January 5, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts

FDA approves Boxed Warning about increased risk of blood clots and death with higher dose of arthritis and ulcerative colitis medicine tofacitinib (Xeljanz, Xeljanz XR)
Listen to an audio podcast of the July 26, 2019 FDA Drug Safety Communication on FDA approval of Boxed Warning about increased risk of blood clots and death with higher dose of arthritis and ulcerative colitis medicine tofacitinib (Xeljanz, Xeljanz XR). (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - December 21, 2019 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts

Effect of FMT on Ulcerative Colitis, HSCT for MS, Review of Penicillin Allergy, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 15, 2019 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - January 15, 2019 Category: General Medicine Authors: JAMA Network Source Type: podcasts

PodMed – Week of May 8, 2017
This week’s topics include lowering cholesterol and outcomes, a new agent for ulcerative colitis, handgun purchases after mass shooting events, and bystander CPR and long term outcomes. Program notes: 0:31 Handgun purchases after mass shootings 1:31 Tripled over time period 2:31 Constraints on gun research 2:45 Bystander CPR and use of defibrillators 3:45 More likely […] (Source: Johns Hopkins Medicine Weekly Health News)
Source: Johns Hopkins Medicine Weekly Health News - May 5, 2017 Category: Consumer Health News Authors: Elizabeth Tracey Tags: Digestive Disorders Heart And Vascular PodMed Safety Source Type: podcasts

Crohn's disease: The Lancet: March 1, 2017
Subra Kugathasan discusses his Article which creates a risk-stratification model to predict the risk of developing complications in paediatric patients with newly diagnosed Crohn ’s disease. (Source: Listen to The Lancet)
Source: Listen to The Lancet - March 2, 2017 Category: General Medicine Authors: The Lancet Source Type: podcasts